A systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs.
about
Conducting systematic reviews of intervention questions II: Relevance screening, data extraction, assessing risk of bias, presenting the results and interpreting the findings.Immunomodulatory drugs and their application to the management of canine immune-mediated disease.Oral cyclosporine treatment in dogs: a review of the literature.Concurrent short-term use of prednisolone with cyclosporine A accelerates pruritus reduction and improvement in clinical scoring in dogs with atopic dermatitisA blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA).Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment.Bioequivalence study between two formulations of ciclosporin A (Cyclavance® oral solution and Atopica® soft capsules) following a single oral administration to dogsRepeated oral dose tolerance in dogs treated concomitantly with ciclosporin and oclacitinib for three weeksEfficacy of dimetinden and hydroxyzine/chlorpheniramine in atopic dogs: a randomised, controlled, double-blinded trial.Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches.Life-long diseases need life-long treatment: long-term safety of ciclosporin in canine atopic dermatitis.Ciclosporin 10 years on: indications and efficacy.Effects of cyclosporin A and cilomilast on activated canine, murine and human keratinocytes.Evaluation of Rickettsia japonica pathogenesis and reservoir potential in dogs by experimental inoculation and epidemiologic survey.Opportunistic fungal infections in dogs treated with ciclosporin and glucocorticoids: eight cases.Voluntary acceptance and consumption of two oral ciclosporin formulations in dogs: two randomised, controlled studiesGene (mRNA) expression in canine atopic dermatitis: microarray analysis.Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis.Evaluation of azithromycin in systemic and toothpaste forms for the treatment of ciclosporin-associated gingival overgrowth in dogs.Evaluation of immunosuppressive regimens for immune-mediated haemolytic anaemia: a retrospective study of 42 dogs.Adverse events in 50 cats with allergic dermatitis receiving ciclosporin.The effect of ketoconazole on whole blood and skin ciclosporin concentrations in dogs.Therapeutic effectiveness of calcineurin inhibitors in canine vesicular cutaneous lupus erythematosus.Comparison of the stability and pharmacokinetics in dogs of modified ciclosporin capsules stored at -20°C and room temperature.The effects of skin disease on the penetration kinetics of hydrocortisone through canine skin in vitro.Ciclosporin A therapy is associated with disturbances in glucose metabolism in dogs with atopic dermatitisGuidelines for Symptomatic Medical Treatment of Canine Atopic Dermatitis
P2860
Q30829504-3B682BB4-6D69-4C15-A2EF-385EF3084446Q33393823-A1F0D249-11B7-40D8-B705-C527AE85E4C3Q34392104-1B40F08F-259E-4803-B7D3-4171B040EEBFQ34978147-8F75AD44-AB01-4729-8F32-24B6CB14CF5CQ35194645-D90AEE74-92BC-46A5-B9F4-DBD950054F2FQ35746839-CA15D568-142D-4EFA-B2A5-12847F24D230Q35803068-99CB1FED-1F72-4B6F-BCC8-61F2664CD4EBQ35955166-B096B133-663D-47F7-A32E-13BB74F9B9E3Q36533132-F3C11A81-5773-4541-AE01-8769AC205C75Q37576555-82436C74-931C-461F-AD63-7A8485E0EFF9Q37634944-AE3FEDE2-D1CE-411E-94C7-8F6FD12CD608Q38200540-E0292DCB-0AEC-4D53-8370-396B770CE115Q38200541-4EC906F4-A445-4D91-A81B-816AA0BEED3CQ40159932-8E2DA4B5-C9CB-4384-AE6D-19BCEE35EB24Q40345207-880585D0-F99F-4C94-AA7E-0B6EA930A3D4Q41219094-F342374E-2104-4349-A8B8-EE22047E7C48Q41825444-F0FD8AF0-2F18-46E7-9433-756999F26209Q42648107-D3C7E083-8621-4F68-9503-DDE9AD2DAC07Q43067638-2809491B-E1DE-4A66-B15C-64EFB6A58D41Q43605428-E7B6051F-28E3-4CCA-B7F5-5C9C611BE4FBQ43923331-051B0296-C84D-4EE5-841B-EDBAAF54D21DQ44368278-93498E12-A753-4662-880F-35D73D291663Q44634059-C42BA3E0-6F7B-4096-A083-1E40A124A601Q44871902-8A346313-1BE3-4B14-816E-8B15EC1DB4FAQ48158348-997154C0-83A7-4CA7-B6BD-66FAB39E60ACQ52719693-8FFE2617-F462-4DCB-9864-8BC7C408B6F5Q58772753-8A7632D8-E3B2-423E-89E1-51871A769677Q58796340-051E21F0-3B9F-45C8-A917-75C52EA25322
P2860
A systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
A systematic review and meta-a ...... of atopic dermatitis in dogs.
@ast
A systematic review and meta-a ...... of atopic dermatitis in dogs.
@en
type
label
A systematic review and meta-a ...... of atopic dermatitis in dogs.
@ast
A systematic review and meta-a ...... of atopic dermatitis in dogs.
@en
prefLabel
A systematic review and meta-a ...... of atopic dermatitis in dogs.
@ast
A systematic review and meta-a ...... of atopic dermatitis in dogs.
@en
P2860
P1476
A systematic review and meta-a ...... t of atopic dermatitis in dogs
@en
P2093
Jean Steffan
Ralf Mueller
P2860
P356
10.1111/J.1365-3164.2005.00491.X
P577
2006-02-01T00:00:00Z